Advertisement
Advertisement

AGIO

AGIO logo

Agios Pharmaceuticals, Inc.

27.72
USD
Sponsored
-0.59
-2.08%
Jan 29, 12:07 UTC -5
Open

AGIO Earnings Reports

Positive Surprise Ratio

AGIO beat 26 of 39 last estimates.

67%

Next Report

Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.25M
/
-$1.98
Implied change from Q3 25 (Revenue/ EPS)
-4.86%
/
+11.24%
Implied change from Q4 24 (Revenue/ EPS)
+14.20%
/
+37.50%

Agios Pharmaceuticals, Inc. earnings per share and revenue

On Oct 30, 2025, AGIO reported earnings of -1.78 USD per share (EPS) for Q3 25, beating the estimate of -1.93 USD, resulting in a 8.09% surprise. Revenue reached 12.88 million, compared to an expected 10.63 million, with a 21.22% difference. The market reacted with a +2.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.98 USD, with revenue projected to reach 12.25 million USD, implying an increase of 11.24% EPS, and decrease of -4.86% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Agios Pharmaceuticals, Inc. reported EPS of -$1.78, beating estimates by 8.09%, and revenue of $12.88M, 21.22% above expectations.
The stock price moved up 2.91%, changed from $41.96 before the earnings release to $43.18 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 12 analysts, Agios Pharmaceuticals, Inc. is expected to report EPS of -$1.98 and revenue of $12.25M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement